Lee’s Pharmaceutical Holdings Ltd (HKG: 0950), a China-based pharmaceutical company, has announced that its subsidiary, Zhaoke Ophthalmology Ltd (HKG: 6622), has entered into a strategic partnership with China’s Eye Valley. The collaboration aims to develop innovative and generic drugs in the field of ophthalmology and will lead to the establishment of the “China’s Eye Valley-Zhaoke Ophthalmology Innovative Drug Research Institute.” Financial details of the agreement were not disclosed.
The partnership will leverage the resource strengths of both companies to engage in substantive cooperation across various areas, including innovative research, clinical trials, product registration, technical training, and production and sales. The focus will be on developing treatments for a range of eye conditions, such as dry eye, myopia, presbyopia, wet age-related macular degeneration, diabetic macular edema, and glaucoma.- Flcube.com
